Plain-English translation of NCT06595212 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study invites twins—where at least one twin has ALS (amyotrophic lateral sclerosis) or frontotemporal dementia—to participate in an Italian research program. Researchers will collect blood and other biological samples, along with detailed health and lifestyle information, to understand how genetic and environmental factors influence these neurodegenerative diseases. By studying identical and fraternal twin pairs, some where both are affected and some where only one is affected, scientists hope to uncover protective factors and disease mechanisms.
ALS and frontotemporal dementia are serious diseases that run in families, but scientists don't fully understand why some people develop them while others with similar genetics don't. By studying twins—who share either all or half their genes—researchers can separate the effects of genetics from environmental factors like pesticide exposure, diet, and lifestyle, and discover biological clues that might lead to better treatments.
You likely qualify if…
You likely don't qualify if…
You and your twin would visit the research center for baseline assessments, where you'll complete medical evaluations, answer questions about your health history and lifestyle exposures, undergo brain imaging and nerve function tests, and donate blood samples. The study will follow you over time with repeat visits to track how the disease progresses and how your biology changes, allowing researchers to understand which biological changes are part of the disease itself versus responses to it.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Italy